urethral bulking agent

urethral bulking agent

Urogynecology An injectable hydrogel composed of a biocompatible recombinant protein polymer used to bulk tissue about the intrinsic sphincter to provide complete closure and urinary control for ♀ with incontinence due to intrinsic sphincter deficiency. See Urinary incontinence.
References in periodicals archive ?
We also offer Macroplastique, an injectable urethral bulking agent for the treatment of adult female stress urinary incontinence primarily due to intrinsic sphincter deficiency.
Use of the urethral bulking agent Tegress is strongly associated with urethral erosions and urinary fistulas.
Ethylene Vinyl Alcohol Copolymer Erosions After Use as a Urethral Bulking Agent.
Injectable Teflon was widely used as a urethral bulking agent in the 1950s and 1960s and was effective, but it has been largely abandoned because of fear that the Teflon would migrate to other tissues, as well as other safety issues.
That leaves two materials--collagen and microcarbon beads--that have been approved by the Food and Drug Administration as urethral bulking agents.
The urethral bulking agent Uryx improved stress urinary incontinence comparably or better than Contigen 12 months after treatment in a multicenter study presented at the annual meeting of the American Urogynecologic Society.
Tissue Science Laboratories plc (LSE:TSL), the medical devices company specialising in human tissue replacement and repair, announces further positive clinical results for its porcine-derived collagen product, Permacol(R) injection, as a Urethral Bulking Agent (UBA) in the treatment of Urinary Stress Incontinence (USI).
Funds will be used to support the company's product development efforts, including preclinical development of MTI's EMBOLYX technology as a urethral bulking agent for incontinence and the initiation of human clinical studies.
Genyx Medical is currently seeking an initial round of financing to provide support for its product development efforts, through the completion of preclinical testing of EMBOLYX as a urethral bulking agent for incontinence, and initiation of human clinical trials.
URINARY INCONTINENCE TREATMENT DEVICE MARKET - Total Urinary Catheter Market - Total Urinary Incontinence Device Market - Incontinence Management Implantable Device Market - Urethral Bulking Agent Market - Urinary Drainage Bag Market 4.
Food and Drug Administration-approved urethral bulking agents include collagen (Conti-gen), calcium hydroxylapatite (Coaptite), and carbon bead particles (Durasphere).
Targeted products include urethral bulking agents for the treatment of stress urinary incontinence, dermal augmentation products for cosmetic and reconstructive surgery, surgical adhesives and sealants, scaffolds for wound healing and tissue engineering, and depots for local drug delivery.